Dark Forest Capital Management LP Acquires 23,270 Shares of R1 RCM Inc. (NASDAQ:RCM)

Dark Forest Capital Management LP increased its holdings in shares of R1 RCM Inc. (NASDAQ:RCM) by 67.5% in the second quarter, Holdings Channel.com reports. The fund owned 57,749 shares of the healthcare provider’s stock after buying an additional 23,270 shares during the quarter. Dark Forest Capital Management LP’s holdings in R1 RCM were worth $725,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of RCM. Advisors Asset Management Inc. bought a new position in R1 RCM in the 1st quarter worth about $27,000. ANTIPODES PARTNERS Ltd bought a new stake in R1 RCM during the 2nd quarter valued at $86,000. QRG Capital Management Inc. purchased a new stake in shares of R1 RCM in the 1st quarter worth $132,000. Caas Capital Management LP bought a new position in shares of R1 RCM during the 4th quarter worth $148,000. Finally, CIBC Asset Management Inc purchased a new position in shares of R1 RCM during the second quarter valued at $149,000. Hedge funds and other institutional investors own 61.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on RCM shares. Morgan Stanley cut shares of R1 RCM from an “overweight” rating to an “equal weight” rating in a report on Thursday, August 8th. Leerink Partners downgraded shares of R1 RCM from an “outperform” rating to a “market perform” rating and dropped their price objective for the company from $17.00 to $14.30 in a research note on Thursday, August 1st. TD Cowen reissued a “hold” rating and issued a $14.30 price objective (down previously from $20.00) on shares of R1 RCM in a research note on Monday, August 5th. Leerink Partnrs cut R1 RCM from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, Stephens lowered R1 RCM from an “overweight” rating to an “equal weight” rating in a research report on Thursday, August 1st. Thirteen research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, R1 RCM currently has a consensus rating of “Hold” and an average target price of $15.41.

R1 RCM Stock Up 0.1 %

NASDAQ:RCM opened at $14.17 on Friday. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.77. R1 RCM Inc. has a twelve month low of $8.87 and a twelve month high of $15.43. The company has a market cap of $5.98 billion, a PE ratio of -177.13 and a beta of 0.84. The company’s 50 day moving average is $13.89 and its two-hundred day moving average is $13.02.

R1 RCM (NASDAQ:RCM) last issued its quarterly earnings results on Wednesday, August 7th. The healthcare provider reported ($0.02) EPS for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.03. The company had revenue of $627.90 million during the quarter, compared to analysts’ expectations of $633.10 million. R1 RCM had a negative return on equity of 1.44% and a negative net margin of 1.68%. The business’s quarterly revenue was up 12.0% on a year-over-year basis. Analysts anticipate that R1 RCM Inc. will post -0.24 EPS for the current year.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.